These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37703661)

  • 21. lncRNA HOTAIR promotes ROS generation and NLRP3 inflammasome activation by inhibiting Nrf2 in diabetic retinopathy.
    You H; Li H; Gou W
    Medicine (Baltimore); 2023 Sep; 102(37):e35155. PubMed ID: 37713847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The IL-23/IL-17 axis promotes the formation of retinal neovascularization by activating the NLRP3 inflammasome in macrophages in an experimental retinopathy mouse model.
    Sui A; Chen X; Yao Y; Yao Y; Shen X; Zhu Y; Xie B
    Immunology; 2021 Dec; 164(4):803-816. PubMed ID: 34396536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.
    Hussein KA; Choksi K; Akeel S; Ahmad S; Megyerdi S; El-Sherbiny M; Nawaz M; Abu El-Asrar A; Al-Shabrawey M
    Exp Eye Res; 2014 Aug; 125():79-88. PubMed ID: 24910902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D
    Lu L; Lu Q; Chen W; Li J; Li C; Zheng Z
    J Diabetes Res; 2018; 2018():8193523. PubMed ID: 29682582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ASK1/p38‑mediated NLRP3 inflammasome signaling pathway contributes to aberrant retinal angiogenesis in diabetic retinopathy.
    Zou W; Luo S; Zhang Z; Cheng L; Huang X; Ding N; Pan Y; Wu Z
    Int J Mol Med; 2021 Feb; 47(2):732-740. PubMed ID: 33416127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor-A
    Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
    Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prodrug of epigallocatechin-3-gallate alleviates high glucose-induced pro-angiogenic factor production by inhibiting the ROS/TXNIP/NLRP3 inflammasome axis in retinal Müller cells.
    Du J; Wang Y; Tu Y; Guo Y; Sun X; Xu X; Liu X; Wang L; Qin X; Zhu M; Song E
    Exp Eye Res; 2020 Jul; 196():108065. PubMed ID: 32407725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the NLRP3 inflammasome in diabetic retinopathy: From pathogenesis to therapeutic strategies.
    Yang Y; Jiang G; Huang R; Liu Y; Chang X; Fu S
    Biochem Pharmacol; 2023 Jun; 212():115569. PubMed ID: 37100255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys.
    Hou Y; Wang Q; Han B; Chen Y; Qiao X; Wang L
    Cell Death Dis; 2021 May; 12(6):523. PubMed ID: 34021126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C1q/TNF-related protein-9 attenuates retinal inflammation and protects blood-retinal barrier in db/db mice.
    Li W; Ma N; Liu MX; Ye BJ; Li YJ; Hu HY; Tang YH
    Eur J Pharmacol; 2019 Jun; 853():289-298. PubMed ID: 30978318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysfunctional Nurr1 promotes high glucose-induced Müller cell activation by up-regulating the NF-κB/NLRP3 inflammasome axis.
    Li W; Liu X; Tu Y; Ding D; Yi Q; Sun X; Wang Y; Wang K; Zhu M; Mao J
    Neuropeptides; 2020 Aug; 82():102057. PubMed ID: 32461025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy.
    Mugisho OO; Aryal J; Shome A; Lyon H; Acosta ML; Green CR; Rupenthal ID
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPARα Agonist Stimulated Angiogenesis by Improving Endothelial Precursor Cell Function Via a NLRP3 Inflammasome Pathway.
    Deng Y; Han X; Yao Z; Sun Y; Yu J; Cai J; Ren G; Jiang G; Han F
    Cell Physiol Biochem; 2017; 42(6):2255-2266. PubMed ID: 28817808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
    Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
    J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulation of the NLRP3 Inflammasome in Diabetic Retinopathy and Potential Therapeutic Targets.
    Raman KS; Matsubara JA
    Ocul Immunol Inflamm; 2022 Feb; 30(2):470-478. PubMed ID: 33026924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of leukemia inhibitory factor against high-glucose-induced human retinal endothelial cell dysfunction.
    Wang L; Wu Q; Wang RQ; Wang RZ; Wang J
    Arch Physiol Biochem; 2023 Feb; 129(1):33-40. PubMed ID: 32658632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated microRNA-20b-3p and reduced thioredoxin-interacting protein ameliorate diabetic retinopathy progression by suppressing the NLRP3 inflammasomes.
    Wang S; Du S; Lv Y; Wang W; Zhang F
    IUBMB Life; 2020 Jul; 72(7):1433-1448. PubMed ID: 32150340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection of Mcc950 against high-glucose-induced human retinal endothelial cell dysfunction.
    Zhang Y; Lv X; Hu Z; Ye X; Zheng X; Ding Y; Xie P; Liu Q
    Cell Death Dis; 2017 Jul; 8(7):e2941. PubMed ID: 28726778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.